Meditation With Virtual Reality for Cancer Pain Relief in the Pain Therapy and Palliative Care Service

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorEmily Santos Montarroyos

About this trial

Cancer is a disabling, challenging and growing global disease. Although early diagnosis and adequate treatment of oncological disease have been developing rapidly, a large part of the population remains without access to specialized services and routinely evolve to symptoms and sequelae with uncontrolled pain, worse quality of life and suffering. Complementary therapies to control pain and improve the well-being of cancer patients are fundamental tools of integrative oncology medicine. This study proposes to use immersive virtual reality to encourage cancer patients to carry out the regular practice of meditation, as an effective tool in pain management and in the search for a better quality of life, based on a structured intervention that encourages autonomy as important part of your treatment. Two studies will be carried out at the Pain Therapy and Palliative Care Service of the Amazonas State Oncology Control Center Foundation (FCECON). Study 1 will be a cross-sectional study to describe the variables associated with the diagnosis and treatment of patients' pain and Study 2 will be a Randomized Controlled Trial that will analyze the impact of an intervention performed with meditation through immersive virtual reality for pain relief. pain in these patients. It is expected that the regular practice of meditation through immersive virtual reality will promote pain relief and improve the quality of life of cancer pain patients.

Eligibility criteria

Qualifiers

Be followed up at the Pain Therapy and Palliative Care Service (STDCP) to control symptoms resulting from any type of cancer at any stage;

Have a diagnosis of chronic pain, recorded in the medical records.

Be between 18 and 75 years old on the date of the first collection;

Be able to understand Portuguese (read and write);

Disqualifiers

Indigenous patients (due to cultural and linguistic peculiarities and special legislation);

Patients with records of serious psychiatric illnesses (DSM-5 - Diagnostic and Statistical Manual of Mental Disorders - schizophrenia, schizotypal disorders, delusional disorders, borderline and dementias);

Impairment of the ability to understand or communicate based on the researcher's assessment;

Report of discomfort with the use of Immersive Virtual Reality;

Trial design

Treatments tested in this trial

  • Case group
  • Active control group
  • Passive control group

Treatment groups

129 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Emily Santos Montarroyos

Lead sponsor

FUNDAÇÃO CENTRO DE CONTROLE DE ONCOLOGIA DO ESTADO DO AMAZONAS

Sponsor institution

AC Camargo Cancer Center

Collaborator